HBK Investments’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-200,000
Closed -$3.87M 564
2022
Q1
$3.87M Sell
200,000
-75,000
-27% -$1.72M 0.02% 320
2021
Q4
$8.99M Sell
275,000
-25,000
-8% -$1.01M 0.03% 138
2021
Q3
$12.3M Sell
300,000
-50,000
-14% -$1.81M 0.05% 95
2021
Q2
$12.6M Hold
350,000
0.04% 101
2021
Q1
$13.7M Hold
350,000
0.06% 80
2020
Q4
$14.1M Buy
350,000
+25,000
+8% +$1.15M 0.09% 94
2020
Q3
$18.1M Buy
+325,000
New +$17.2M 0.13% 68

Other funds holding GDRX

HBK Investments's GDRX Position: Q2 2022 in Review

HBK Investments sold out of GoodRx Holdings (GDRX) in Q2 2022, closing a stake of 200,000 shares — an estimated $3.87M sold.

HBK Investments first reported a position in GDRX in Q3 2020 and held it in 7 quarters. The position peaked at $18.1M in Q3 2020. 174 funds tracked by Wall St. Rank hold GDRX as of Q2 2022.

  • HBK Investments reported no remaining GoodRx Holdings position as of Q2 2022 after selling out during the quarter.
  • HBK Investments sold 200,000 GoodRx Holdings shares in Q2 2022, an estimated $3.87M.
  • HBK Investments first reported a position in GoodRx Holdings in Q3 2020 and held it in 7 quarters.
  • HBK Investments's GoodRx Holdings position peaked at $18.1M in Q3 2020.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2022.

Based on HBK Investments's 13F filing for Q2 2022, filed 15 Aug 2022.